P-ISSN 2587-2400 | E-ISSN 2587-196X
EJMO. 2018; 2(3): 182-185 | DOI: 10.14744/ejmo.2017.43434
1Department of Internal Medicine, Division of Endocrinology and Metabolism, Dumlupınar University Kütahya Evliya Çelebi Training and Research Hospital, Kütahya, Turkey, 2Department of Nuclear Medicine, Dumlupınar University Kütahya Evliya Çelebi Training and Research Hospital, Kütahya, Turkey,
Cite This Article
Kuzu F, Akdemir E. Subacute Thyroiditis During Peginterferon Alfa Therapy for Chronic Hepatitis Delta. EJMO. 2018; 2(3): 182-185Full Text PDF PDF Download
Subacute Thyroiditis During Peginterferon Alfa Therapy for Chronic Hepatitis Delta
Fatih Kuzu1, Elif Neslihan Akdemir21Department of Internal Medicine, Division of Endocrinology and Metabolism, Dumlupınar University Kütahya Evliya Çelebi Training and Research Hospital, Kütahya, Turkey, 2Department of Nuclear Medicine, Dumlupınar University Kütahya Evliya Çelebi Training and Research Hospital, Kütahya, Turkey,
Subacute thyroiditis is a nonsuppurative inflammation of the thyroid gland. Although there are case reports on the formation of subacute thyroiditis in patients with hepatitis C virus (HCV) and hepatitis B virus (HBV) receiving interferon treatment, there are no reports regarding the development of subacute thyroiditis in patients with hepatitis D virus (HDV) receiving interferon treatment. Here, we present the case of a patient with subacute thyroiditis receiving peginterferon alfa-2a for chronic HDV and to our knowledge this is the first report in the literature.
Cite This Article
Kuzu F, Akdemir E. Subacute Thyroiditis During Peginterferon Alfa Therapy for Chronic Hepatitis Delta. EJMO. 2018; 2(3): 182-185
Corresponding Author: Fatih Kuzu